Aaron Fernandes published a dataset on 2026-04-17 from a proof-of-concept study demonstrating the bioprinting of intestinal stem cells derived from pre-term infant gut organoids. The dataset likely contains data on cell viability and phenotype retention after printing using a Reactive Jet Impingement (ReJI) technique. The cells were maintained in a collagen–alginate–fibrin (CAF) hydrogel.
Use Cases
- Train models to predict cell viability post-bioprinting based on assay results.
- Analyze stem cell phenotype retention in defined hydrogels based on confocal imaging data.
- Compare lineage differentiation capacity between bioprinted and control samples.
Strengths
- Dataset is associated with a specific proof-of-concept study demonstrating a novel bioprinting technique.
- Data includes results from multiple validation assays (Live/Dead, PrestoBlue, confocal imaging).
- License is CC-BY-4.0, permitting broad reuse with attribution.
Limitations
- Row count, file formats, and column-level documentation are unknown.
- Description metadata is limited; actual data quality requires manual inspection after download.
- The dataset is described as a preliminary proof-of-concept, which may indicate a limited sample size.
Provenance
- Source
- figshare, author Aaron Fernandes.
- Collection Method
- Stem cells were isolated from established pre-term ileal organoids, embedded in a hydrogel, and subjected to ReJI-based printing.
- Freshness
- Last updated 2026-04-17 10:26:20; freshness should be verified.